KOSPI · Industrials · ₩50B
₩2,030+1.50%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 6.5% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“이번 분기 안정 사업 위에 바이오 허가 전략을 세우고 있어요.”
In the company's words · 2026 2분기 filing